Zygun D - Search Results

1

Multi-modality neuro-monitoring: conventional clinical trial design.

Georgiadis AL, Palesch YY, Zygun D, Hemphill JC 3rd, Robertson CS, Leroux PD, Suarez JI; Second Neurocritical Care Research Conference Investigators. Georgiadis AL, et al. Among authors: zygun d. Neurocrit Care. 2015 Jun;22(3):369-77. doi: 10.1007/s12028-015-0134-9. Neurocrit Care. 2015. PMID: 25832350 Review.

2

Angiotensin II for the Treatment of Vasodilatory Shock.

Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, Busse LW, Altaweel L, Albertson TE, Mackey C, McCurdy MT, Boldt DW, Chock S, Young PJ, Krell K, Wunderink RG, Ostermann M, Murugan R, Gong MN, Panwar R, Hästbacka J, Favory R, Venkatesh B, Thompson BT, Bellomo R, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Deane AM; ATHOS-3 Investigators. Khanna A, et al. N Engl J Med. 2017 Aug 3;377(5):419-430. doi: 10.1056/NEJMoa1704154. Epub 2017 May 21. N Engl J Med. 2017. PMID: 28528561 Free article. Clinical Trial.

3

Human albumin administration in subarachnoid hemorrhage: results of an international survey.

Suarez JI, Martin RH, Calvillo E, Zygun D, Flower O, Wong GK, Bershad EM, Venkatasubba Rao CP, Georgiadis A, Jichici D, Leroux PD. Suarez JI, et al. Among authors: zygun d. Neurocrit Care. 2014 Apr;20(2):277-86. doi: 10.1007/s12028-013-9942-y. Neurocrit Care. 2014. PMID: 24378920

4

Human Albumin Use in Adults in U.S. Academic Medical Centers.

Suarez JI, Martin RH, Hohmann SF, Calvillo E, Bershad EM, Venkatasubba Rao CP, Georgiadis A, Flower O, Zygun D, Finfer S. Suarez JI, et al. Among authors: zygun d. Crit Care Med. 2017 Jan;45(1):e16-e22. doi: 10.1097/CCM.0000000000002010. Crit Care Med. 2017. PMID: 27632679

5

Venous Thromboembolism Prophylaxis in Neurocritical Care Patients: Are Current Practices, Best Practices?

Sauro KM, Soo A, Kramer A, Couillard P, Kromm J, Zygun D, Niven DJ, Bagshaw SM, Stelfox HT. Sauro KM, et al. Among authors: zygun d. Neurocrit Care. 2019 Apr;30(2):355-363. doi: 10.1007/s12028-018-0614-9. Neurocrit Care. 2019. PMID: 30276615

6

Can we demonstrate the efficacy of monitoring?

Zygun D. Zygun D. Eur J Anaesthesiol Suppl. 2008;42:94-7. doi: 10.1017/S026502150700347X. Eur J Anaesthesiol Suppl. 2008. PMID: 18289424

7

Decompressive Craniectomy in Patients with Traumatic Brain Injury: Are the Usual Indications Congruent with Those Evaluated in Clinical Trials?

Kramer AH, Deis N, Ruddell S, Couillard P, Zygun DA, Doig CJ, Gallagher C. Kramer AH, et al. Neurocrit Care. 2016 Aug;25(1):10-9. doi: 10.1007/s12028-015-0232-8. Neurocrit Care. 2016. PMID: 26732269

8

Continuous Assessment of "Optimal" Cerebral Perfusion Pressure in Traumatic Brain Injury: A Cohort Study of Feasibility, Reliability, and Relation to Outcome.

Kramer AH, Couillard PL, Zygun DA, Aries MJ, Gallagher CN. Kramer AH, et al. Neurocrit Care. 2019 Feb;30(1):51-61. doi: 10.1007/s12028-018-0570-4. Neurocrit Care. 2019. PMID: 29987688

9

Do neurocritical care units save lives? Measuring the impact of specialized ICUs.

Kramer AH, Zygun DA. Kramer AH, et al. Neurocrit Care. 2011 Jun;14(3):329-33. doi: 10.1007/s12028-011-9530-y. Neurocrit Care. 2011. PMID: 21424177 No abstract available.

10

Factors associated with the withdrawal of life-sustaining therapies in patients with severe traumatic brain injury: a multicenter cohort study.

Côte N, Turgeon AF, Lauzier F, Moore L, Scales DC, Bernard F, Zarychanski R, Burns KE, Meade MO, Zygun D, Simard JF, Boutin A, Brochu JG, Fergusson DA. Côte N, et al. Among authors: zygun d. Neurocrit Care. 2013 Feb;18(1):154-60. doi: 10.1007/s12028-012-9787-9. Neurocrit Care. 2013. PMID: 23099846

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page